20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Recommended Webinars & Conferences

21st World Hematology Congress

Madrid, Spain

29th International Oncology Summit

Chicago, USA

37th Global Summit on Pediatrics

Madrid, Spain

14th Annual Conference on Stem Cells and Regenerative Medicine

Kuala Lumpur, Malaysia
Journal Flyer
Flyer image

David F Stroncek

David F Stroncek

David F Stroncek
Department of Transfusion Medicine
Warren G. Magnuson Clinical Center, USA


Dr. David Stroncek completed his undergraduate and medical school degrees, an internal medicine residency and a hematology/oncology fellowship at the University of Minnesota. He then joined the faculty of the University of Minnesota Medical School, Laboratory Medicine and Pathology Department as Associate Medical Director of the blood blank. He helped establish the National Marrow Donor Program (NMDP) and was the organization’s first medical director. During his four years as medical director of the NMDP, the program coordinated their first unrelated donor transplant and subsequently increased the number of employees and marrow donations by unrelated individuals. He has served on several NMDP committees as president of the council of the NMDP and as a member of the NMDP board of directors. Dr. Stroncek came to the NIH Clinical Center Department of Transfusion Medicine (DTM) in 1996 as chief of the Laboratory Service Section. In this role, he directed the HLA and Transfusion Services Laboratories. He has published more than 170 articles in scientific journals and has written several book chapters. He has served on the editorial boards of several scientific journals.

Research Interest

Leukocyte antibodies to transfusion reactions and advanced understanding of the molecular basis of neutrophil-specific antigens.